Refractive Status and Accommodation Response Under Different Experimental Conditions.
NCT ID: NCT06331780
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
55 participants
INTERVENTIONAL
2024-02-22
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People
NCT07297810
Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near
NCT02679313
Comparative Study and Validation of New Methodologies for Measuring Addition
NCT06963138
Investigation of the Accuracy of a Low-cost, Portable, Autorefractor to Provide Well-tolerated Eyeglass Prescriptions
NCT03615612
Investigational Study of Accommodation Triggering and Control to Allow for the Performance of Refraction Measurements
NCT03957408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The clinical development stage is pilot stage as defined in ISO 14155:2020 (Annex I section 1.3.2).This clinical investigation is an exploratory clinical investigation as mentioned in the Medical Device Regulation EU 745/2017, also named early feasibility clinical investigation in the ISO 14155:2020. The necessity of such clinical investigations is more precisely described by the Food and Drug Administration (FDA) (Attachment E CDRH Final Guidance Cover Sheet) and Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM), where they detail the importance of exploratory studies in pivotal investigation design.
Medical devices often undergo design improvement during development, with refinement during lifecycles beginning with early research, extending through investigational use and initial marketing of the approved or cleared product, and continuing to subsequently approved or cleared commercial device versions.
Objectives and hypotheses of the clinical investigation
This clinical investigation explores new ways of measuring accommodative response, particularly regarding the dynamics and amplitude of response: we chose to vary several parameters.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closed-field Aberrometer
Objective refraction at different distances with Shack-Hartmann Aberrometer
Visual acuity
VA will be measured with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart
Objective refraction
Objective refraction will be measured using an auto-kerato-refractometer/aberrometer
Objective monocular accommodation amplitude measurement
Objective monocular accommodation amplitude measurements are obtained dynamically by measuring the subject's dioptric change while the participant focuses on a virtual object that moves from distance
Subjective monocular accommodation amplitude measurement with the "Push-Up" method
The subjective monocular accommodation amplitude measurements are carried out by the "push-up" method and proceeds as follows:
* The ECP presents a near vision test card corresponding to a 0.8 (8/10) acuity line, or the smallest readable line if acuity is poor, or the smallest readable text.
* Instructions to the subject: "Look at the smallest line of letters and try to see them clearly for as long as possible when I bring them closer; tell me when they start to blur and stay blurred.
* The ECP slowly brings the test card closer
* The ECP note the distance of the test card from the glasses as soon as the vision is blurred. Continue to move the test closer to check that vision remains blurred.
The amount of accommodation in this eye is equal to the proximity (= 1/distance) of the test when the blur is just perceived.
Subjective monocular accommodation facility measurement with the "Rock" method:
The subjective monocular accommodation facility measurements are carried out by the "Rock" method and proceeds as follows:
* The ECP presents at 40cm a near vision test card corresponding to 80% of the VA.
* The ECP gives to the participant a flipper +/- 2 Dioptre
* Instructions to the subject: "Look at the test" and add the -2.00 D (Sphere) flipper, as soon as it's clear, return the flipper to present a +2.00 D (Sphere), as soon as it's clear, return the flipper etc… You have to do the maximum number of rotations in one minute.
CISS Questionnaire
This questionnaire relating to the use of the near vision will be submitted
Difficulty assessment questionnaire
After each near vision measurement, the participant should rate, on a Visual Analogic Score (0-10), the difficulty encountered, from 0: extremely easy to 10: extremely difficult. The participant may also specify the reasons for the difficulty(ies) encountered during the measurement.
Subjective evaluation questionnaire
A subjective evaluation questionnaire will be submitted to the participants at the end of the visit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visual acuity
VA will be measured with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart
Objective refraction
Objective refraction will be measured using an auto-kerato-refractometer/aberrometer
Objective monocular accommodation amplitude measurement
Objective monocular accommodation amplitude measurements are obtained dynamically by measuring the subject's dioptric change while the participant focuses on a virtual object that moves from distance
Subjective monocular accommodation amplitude measurement with the "Push-Up" method
The subjective monocular accommodation amplitude measurements are carried out by the "push-up" method and proceeds as follows:
* The ECP presents a near vision test card corresponding to a 0.8 (8/10) acuity line, or the smallest readable line if acuity is poor, or the smallest readable text.
* Instructions to the subject: "Look at the smallest line of letters and try to see them clearly for as long as possible when I bring them closer; tell me when they start to blur and stay blurred.
* The ECP slowly brings the test card closer
* The ECP note the distance of the test card from the glasses as soon as the vision is blurred. Continue to move the test closer to check that vision remains blurred.
The amount of accommodation in this eye is equal to the proximity (= 1/distance) of the test when the blur is just perceived.
Subjective monocular accommodation facility measurement with the "Rock" method:
The subjective monocular accommodation facility measurements are carried out by the "Rock" method and proceeds as follows:
* The ECP presents at 40cm a near vision test card corresponding to 80% of the VA.
* The ECP gives to the participant a flipper +/- 2 Dioptre
* Instructions to the subject: "Look at the test" and add the -2.00 D (Sphere) flipper, as soon as it's clear, return the flipper to present a +2.00 D (Sphere), as soon as it's clear, return the flipper etc… You have to do the maximum number of rotations in one minute.
CISS Questionnaire
This questionnaire relating to the use of the near vision will be submitted
Difficulty assessment questionnaire
After each near vision measurement, the participant should rate, on a Visual Analogic Score (0-10), the difficulty encountered, from 0: extremely easy to 10: extremely difficult. The participant may also specify the reasons for the difficulty(ies) encountered during the measurement.
Subjective evaluation questionnaire
A subjective evaluation questionnaire will be submitted to the participants at the end of the visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject declares that his last visit to an ophthalmologist was less than 12 months ago,
* Subjects without a reported pathology, deficit or disorder that can interfere with visual or cognitive functions,
* Subjects, healthy volunteers who have been fully informed of the investigation and signed the informed consent form of the investigation,
* Subjects available for the investigation visits (at least 2 hours),
* Subjects able to appoint a visit in the investigator's site,
* Subjects able to read and understand the protocol (in French), follow the instructions, and give their informed consent approval.
Exclusion Criteria
* Subjects with an astigmatism wearing compensation (or fully compensate by contact lenses) more than 1.00 Dioptres (\>1,00DC) in both eyes,
* Subjects with a best compensated monocular VA \< 8/10 (\>0.1logMAR),
* Persons subject to a legal protection measure (guardianship, curatorship, safeguard of justice, etc.) or unable to express their consent (see Article L 1121-8 of the CSP)
* Persons deprived of their liberty by judicial or administrative decision and persons hospitalised without their consent (article L1121-6 of the CSP),
* Subjects under exclusion period from another investigation,
* Women pregnant or breastfeeding; (Article L1121-5),
* Subjects with a reported neurologic disorder, particularly epileptic or sensory motor troubles,
* Subjects with implanted electronic medical device such as (pacemaker or hearing aid),
* Subjects with a reported severe ocular disease leading to a visual field decrease, VA deficiency or glare sensitivity,
* Subjects with monophtalmia
* Subjects who had ocular surgeries (including aphakia or pseudophakia (intraocular lenses), refractive surgery or trauma),
* Subjects who are ESSILOR INTERNATIONAL employees
* Subjects who are not affiliated to a social security scheme or are beneficiaries of such a scheme (article L1121-8-1 of the CSP).
* Subject with fixation disorder: impossibility to maintain fixation on visual target.
* Subjects who cannot stay comfortable during the tests (e.g. with neck pain ...).
* Pupil abnormality (unusual shape, size \<3mm)
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Essilor International
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jérôme Gillet
Role: PRINCIPAL_INVESTIGATOR
ESSILOR INTERNATIONAL - Division Instruments
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Essilor International - Ci&T 2
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02153-42
Identifier Type: OTHER
Identifier Source: secondary_id
WS10370
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.